The September round up shows that editors and publishers need to be ever vigilant. Data fabrication and falsification will not go away. Funders are becoming alert to this; an Australian institution has been asked to repay a research grant after one of its academics knowingly provided “misleading and incorrect” information. Also of concern, a senior academic has been found to have plagiarised sections of their thesis. The UK placebo controlled cardiac arrest trial poses an interesting ethical dilemma which journals will have to deal with when the results are submitted for publication.
COPE produces guidance and discussion documents to assist editors and the case of the month emphasises the problems editors deal with.
If you would like to contribute items or have other suggestions, as always, please get in touch (contact us here).